Campath alemtuzumab: Phase III data
In the open-label, international Phase III CAM307 trial in 297 treatment-naïve patients, Campath
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
In the open-label, international Phase III CAM307 trial in 297 treatment-naïve patients, Campath